When chronic mesenteric ischemia occurs in a younger, otherwise healthy patient with limited comorbidities, the treatment choice is shaped by the expectation of a longer life ahead — meaning long-term durability of the intervention becomes a central factor.
This protocol addresses younger patients with longer life expectancy and limited comorbidities. In this population, the anticipated benefit of more durable revascularization may justify a higher perioperative risk profile compared to what would be acceptable in older or higher-risk patients.
An open surgical revascularization approach may be considered as the initial procedure for this select group. The specific technique and its appropriateness are determined by anatomy, comorbidities, prior interventions, and provider preference. The complete decision algorithm and all procedural options are in the full protocol.
The aims of treatment are reversal of presenting symptoms — including postprandial abdominal pain, food fear, and diarrhea — and weight gain.
DOI: 10.3390/jcm13051217
Open revascularization may also be appropriate as the initial procedure for select younger, healthier patients with longer life expectancies, assuming that the improved long-term patency offsets the increased perioperative risks.
The choice of open surgical revascularization for CMI should be determined by anatomy, comorbidities, prior interventions, and provider preference.
We recommend revascularization in patients with CMI to reverse their presenting symptoms (ie, weight loss, food fear, diarrhea, postprandial pain) and improve their overall quality of life.
Treatment goals for patients with CMI are to reverse the symptoms, facilitate weight gain, prevent the development of AMI, and improve the patient's overall quality of life.
View source ↗